Wrong. The loss you refer to was for the nine month period, not the quarter. The nine month loss is attributable to the $10M Mona parachute settlement in Q1, 2019. It had nothing to do with operations. Q2 2019 was a $1.3M profit, Q3 2019 was a $1.7M loss - after significant investment in facilities, digital marketing and the e-commerce platform.
Which is why I'm a buyer. Betting on CVSI's investment in sustainable growth and a return to 20% EBITDA margin.
Best value proposition in the hemp CBD space at close to 1X revenue versus CW's 4X revenue. Though I own both names.